The PI3K/AKT/mTOR pathway is thought to play a fundamental oncogenic role in cancers and is activated by the activating events in oncogenes PIK3CA, AKT1/2, and MTOR, or inactivating events in tumor suppressor genes such as PTEN, INPP4B, etc72. This evidence concerns the gene MTOR and cancer.